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Renal extraglomerular vascular immune deposits in IgA glomerulone-
phritis. Kidney biopsies of 425 patients with IgA glomerulonephritis
were studied to reveal the incidence, composition and possible clinical
significance of extraglomerular vascular immune deposits. IgA deposits
were detected in 20 cases, 1gM in 28 (in 5 together with IgA), C3 in 317
and no vascular deposits in 60 cases. C3 and IgA deposits were
granular, resembling mesangial deposits, while 1gM deposits were
lumpy, similar to 1gM deposits in sclerotic and hyalinized glomeruli.
The incidence of vascular lesions in patients with IgA (30%) and C3
deposits (24%) was not significantly higher as compared to those
without vascular deposits (20%), but was significantly higher in patients
with 1gM deposits (68%, P < 0.00004). Only the presence of vascular
1gM deposits correlated significantly with severe glomeruloscierosis,
arterial hypertension and elevated serum creatinine levels (all P <
0.001). We conclude that neither C3 nor IgA deposits, in spite of their
suggested immune complex nature, contribute significantly to the
development of vascular lesions. Lumpy 1gM deposits, probably the
result of insudation of plasma proteins into the blood vessel walls, were
associated with advanced vascular lesions and glomeruloscierosis and
are probably a part of non-immune mediated progression of IgA
glomerulonephritis.
It is now widely accepted that intrarenal vascular disease
plays a significant role in the progression of chronic glomeru-
lonephritis. Kincaid-Smith [1] first drew attention to the wide-
spread vascular lesions in the course of various forms of
glomerulonephritis being disproportionate to the age of the
patient, and the severity and duration of hypertension. Several
further studies of patients with IgA glomerulonephritis (IgA
GN) confirmed her suggestion by revealing a high incidence of
vascular lesions varying from 30% to 66% (2—9]. The majority of
authors found a close correlation between vascular and glomer-
ular sclerosis [2—4, 7, 8, 10, 11] but the interrelationship
between the two lesions, and their pathogenesis remain unclear.
Intrarenal vascular disease used to be interpreted as an effect
of hypertension with resultant renal parenchymal ischemia and
glomerulosclerosis [12, 13]. This concept has changed radically,
and two possible mechanisms have recently been proposed.
According to one, vascular lesions might be a primary feature of
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glomerulonephritis itself [3, 11, 14—16] and according to the
other, vascular lesions might be a part of hyperperfusion injury
[4, 6, 11, 14, 17, 18].
In our biopsy material we have occasionally observed extra-
glomerular vascular deposits of immunoglobulins and comple-
ment components in patients with IgA GN. Surprisingly, little
attention has been paid to these deposits and their possible role
in the development of vascular lesions. There have only been a
few reports, mostly based on a limited number of patients [2,
15, 16] or controversial in relation to the incidence and signifi-
cance of the vascular deposits [19]. The aim of our retrospective
study of 425 patients with IgA GN was therefore to reveal the
incidence, composition and pathogenesis of extraglomerular
vascular deposits of immunoglobulins and complement with
special regard to their significance for the development of
vascular lesions and disease progression.
Methods
Patients
This study included kidney biopsy samples of 425 patients
with immunohistologically and clinically proven IgA GN stud-
ied at the Institute of Pathology in Ljubljana during a period of
10 years. IgA GN represents 35% of all biopsy-proven primary
glomerulonephritides in Slovene population. Patients with He-
noch-Schönlein purpura, systemic lupus erythematosus and
liver diseases, together with specimens with less than 10
glomeruli were excluded from the study.
Hypertension was defined as arterial blood pressure exceed-
ing 140/90 mm Hg. The serum level of creatinine was used as a
clinical indicator of renal function. Values up to 110 tJliter were
considered to be within normal limits.
Light microscopy
All renal specimens obtained by percutaneous needle biopsy
were fixed in Duboscq-Brazil liquid, embedded in paraffin and
sectioned at 3 to 4 microns. The slices were stained with
hematoxylin-eosin, Masson's and Goldner's trichrome staining
methods, periodic acid Schiff (PAS), periodic acid silver methe-
namine (PASM) + Azan, Jones modification of silver impreg-
nation, and van Gieson and Weigert elastic and collagen fiber
staining method.
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Table 1. Clinical data in 425 patients with IgA glomerulonephritis divided into four groups on the basis of the extraglomerular vascular immune
deposit composition patterns
Composition
of vascular
deposits
Total cases
No. %
Mean age
.in years
SD
Male:
female ratio
Arterial
hypertension
No. %
Ele
No.
vated serum
creatinine
%
IgA
1gM, 1gM + IgA
C3
No deposits
Total
20
28
317
60
425
5
7
74
14
32 11"
40 11
31 13"
25 12
31 13
3:la
8:la
3:la
3:1
3:1
7
24
102
16
149
35
86C
32°
27
35
5
19
85
17
126
25°
68b
27°
28
30
Calculated P values are based on comparison to the group without vascular deposits: a not significan, bp < 0.01, P < 0.001
Morphological changes of the extraglomerular arterioles and
small interlobular arteries were evaluated by two independent
observers and were classified as follows: hyalinosis, sclerosis,
intimal fibrosis, fibroelastosis, and undetermined thickening of
the vessel wall.
Glomeruloscierosis was classified on the basis of the percent-
age of the segmentally and globally sclerotic glomeruli. The
finding of 0 to 10% of sclerotic glomeruli was considered to be
within normal limits [20]. Sclerosis affecting 11 to 25% of
glomeruli was classified as mild, 26 to 50% as moderate and
more than 50% as severe glomerulosclerosis.
Immunofluorescence microscopy
Specimens for immunofluorescence were snap-frozen and
stored at —70°C. Frozen tissue was cut in cryostat at 5 p. and
stained by the direct method using FITC-labeled rabbit antisera
monospecific for human IgG, IgA, 1gM, Clq, C3, C4 and
fibrin-related antigen and albumin. All sera were obtained
commercially (Dakopatts, Behringer). The slices were exam-
ined and photographed with a Leitz Orthoplan fluorescence
microscope using specific FITC filters.
We studied the composition, localization and appearance of
extraglomerular vascular immune deposits. Patients were di-
vided into four groups on the basis of the extraglomerular
vascular immune deposit composition pattern.
Group 1. Cases with IgA with or without deposits of comple-
ment components and IgG.
Group 2. Cases with 1gM and cases with 1gM + IgA with or
without deposits of complement components and IgG. Cases
with deposits of 1gM + IgA were included in this group because
in clinical and morphological parameters they resembled pa-
tients with 1gM deposits more than those of group 1.
Group 3. Cases with deposits of C3 with or without other
components of complement.
Group 4. Cases with no vascular immune deposits.
Statistical analysis
Statistical analysis was performed by the chi square test and
analysis of variance. The results were considered statistically
significant at P <0.05.
Results
Incidence and composition of extra glomerular vascular
immune deposits
Using a direct immunofluorescent technique, extraglomerular
vascular immune deposits were detected in 365 of 425 patients
(86%). 1gM was the most frequent immunoglobulin, found in 28
cases (7%). The incidence of vascular deposits of IgA was
similar (25 cases, 6%). IgG was found rarely (4 cases, 1%).
C3 was by far the most common component of the vascular
immune deposits. It was demonstrated in 361 patients (85%).
Early components of complement were less frequent: C4 was
detected in 38 cases (9%) and Clq in 4 (1%).
Fibrin-related antigens and albumin were not detected in
extraglomerular blood vessels in any of our patients.
The clinical data of 425 patients with IgA GN divided into the
four groups is shown in Table 1. The exact extraglomerular
vascular deposit composition patterns in the four groups were
as follows:
Group 1. 20 patients with vascular deposits of IgA. IgA
deposits were accompanied by C3 in all patients, by C4 in six
and by IgG in three patients.
Group 2. 23 patients with vascular 1gM deposits and five
patients with vascular deposits of both 1gM and IgA. 1gM
deposits were accompanied by C3 in all but three patients, by
C4 and/or Clq in nine and by SIgG in one patient.
Group 3. 317 patients with vascular deposits of C3. C3
deposits were accompanied by C4 in 25 and by Clq in two
patients.
Group 4. 60 patients with no vascular immune deposits
detected by direct immunofluorescence.
Localization and appearance of extra glomerular vascular
immune deposits
Immune deposits were localized in small interlobular arteries
in 224 cases (61%), in extraglomerular arterioles in 69 cases
(19%), and in both sites in 72 cases (20%). Larger arteries were
not present in any of the biopsy samples.
Vascular deposits of IgA (Fig. I) as well as accompanying or
isolated deposits of complement components C3 (Fig. 2), C4
and Clq showed a granular pattern in all patients. Vascular
deposits of 1gM (Fig. 3) and accompanying deposits of comple-
ment components, if present, showed a lumpy appearance in all
but one patient.
Incidence and morphology of vascular lesions
Morphological vascular lesions were observed in 139 patients
(33%), namely in six patients (30%) with vascular IgA deposits,
in 19 (68%) with vascular 1gM deposits, in 102 (24%) with C3
deposits and in 12 patients (20%) without vascular deposits. The
incidence of vascular lesions was not significantly higher in
patients with vascular deposits of IgA and C3 as compared to
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Fig. 1. Diffuse granular deposits of IgA
within the glomerular mesangium and the
small blood vessel wall. Direct
immunofluorescence, magnification 252 x.
Fig. 2. Diffuse granular deposits of C3 within
the glomerular mesan glum and
extra glomerular arterioles. Direct
immunofluorescence, magnification 252 X.
those without vascular deposits, while it was significantly
higher in patients with 1gM deposits (P < 0.00004).
Hyalinosis of extraglomerular arterioles and/or small inter-
lobular arteries found in 88 patients (2 1%) was the most
frequent form of light microscopically-detected vascular le-
sions. Fibroelastosis was found in 67 (16%), sclerosis in 22
(5%), intimal fibrosis in 13 (3%), and undetermined thickening
of the vessel wall in six patients (1%). Sixty-eight patients (49%)
of 139 patients with vascular lesions exhibited more than one
morphological form.
The incidence of various forms of morphological vascular
lesions in the four groups with different vascular immune
deposit composition is shown in Table 2. Note that all forms of
vascular lesions were more frequent in patients with vascular
1gM deposits as compared to the others.
Incidence of glomeruloscierosis
The incidence of glomerulosclerosis is shown in Table 3.
The most frequent finding in patients with IgA deposits, in
patients with C3 deposits, as well as in patients without
vascular deposits, was either a "normal" or mild glomerulo-
sclerosis, detected in 15 (75%), 235 (74%) and 45 (75%) patients,
respectively. In contrast, only nine patients (32%) with vascular
1gM deposits revealed "normal" or mild glomerulosclerosis.
Zidar et a!: Vascular immune deposits in IgA nephritis 1447
Fig. 3. Lumpy deposits of 1gM in the
sclerotic segments of the glomerulus and of
the small interlobular artery wall. Direct
immunofluorescence, magnification 252 x.
Table 2. Incidence of various morphological forms of vascular lesions in 425 patients with IgA glomerulonephritis divided into four groups
with different composition of vascular immune deposits
Composition
of vascular
Morphological form of vascular lesions
.
Hyalinosis
.Sclerosis . .Fibroelastosis .Intimal .fibrosis .Undetermined
deposits No. % No. % No. % No. % No. %
IgA 4 20 1 5 5 25 0 0
1gM, IgM + IgA 13 46 6 21 12 43 4 14 2 7
C3 61 19 12 4 43 14 9 3 4 1
No deposits 10 17 3 5 7 12 0 0
Total 88 21 22 5 67 16 13 3 6 1
Table 3. Incidence and severity of glomerulosclerosis in 425 patients with IgA glomerulonephritis divided into four groups in relation to the
different extraglomerular vascular immune deposit composition patterns
Composition
of vascular
Percentage of scierotic glomeruli
Total.10 11—25 >25
deposits No. % No. % No. % No. %
IgA 12 60 3 15 5 25 20 100
1gM, 1gM + IgA 7 25 2 7 19 68' 28 100
C3 173 54 62 20 82 26 317 100
No deposits 37 62 8 13 15 25 60 100
Total 229 54 75 18 121 28 425 100
Calculated P values are based on comparison to the group without vascular deposits: a not significant, bp < 0.001.
The incidence of moderate to severe glomeruloscierosis was
similar in patients with vascular IgA deposits (5 cases, 25%) and
in patients with vascular C3 deposits (82 patients, 26%), and
was virtually identical to that in patients without vascular
deposits (15 patients, 25%), while it was significantly higher in
patients with vascular 1gM deposits (19 cases, 68%, P <
0.0004).
Discussion
Some authors suggest that immune mechanisms might be
important in the development of extraglomerular vascular le-
sions in some forms of immune-mediated glomerulonephritis [3,
11, 14—16, 211. Nevertheless, the reports on vascular IgA
deposits in patients with IgA GN are controversial, and it is not
clear whether or not the immune mechanisms involve the
extraglomerular blood vessels in IgA GN, and if they do with
what incidence and consequence. Cameron et al [19] did not
find any IgA deposits in the extraglomerular blood vessels,
while Clarkson et al reported the incidence of 22 and 25%,
respectively [2, 221. D'Amico et al [8] found faint staining for
IgA in small vessel walls in four of 289 patients with IgA GN.
Other reports are based on a limited number of patients [15, 16,
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21]. In our series of 425 patients, vascular IgA deposits were
demonstrated in 20 patients (5%). In all but one they were
accompanied by deposits of C3. A similar incidence of IgA
deposits was only reported by Vangelista et al [23].
Vascular IgA deposits tend to have a granular appearance
which closely resembles that of the glomerular deposits, thus
suggesting the possibility of immune complex deposition in both
locations [24, 25]. These findings indicate that the basic immune
mechanism suggested to be responsible for the initial glomeru-
lar damage may rarely also involve the extraglomerular blood
vessels. According to the results of our study, this seems to be
of little significance for the development of vascular lesions;
vascular lesions were not significantly more frequent in patients
with vascular IgA deposits as compared to those without
vascular deposits. Furthermore, the incidence of various mor-
phological forms of vascular lesions did not differ significantly
in these patients as compared to ones without deposits.
It is of interest that a similar incidence of extraglomerular
vascular IgA deposits (4%) was found in our patients with
Henoch-SchOnlein purpura. Similarly to patients with IgA GN,
patients with Henoch-SchOnlein purpura who demonstrated
extraglomerular vascular IgA deposits did not have a signifi-
cantly higher incidence of morphological vascular lesions than
those without vascular deposits (Ferluga, unpublished data).
Extraglomerular vascular 1gM deposits, mostly accompanied
by C3, were detected in 28 patients (7%). 1gM deposits were
clearly associated with the advanced forms of the disease since
significantly higher incidences of vascular lesions, severe gb-
meruloscierosis, arterial hypertension and elevated serum cre-
atinine levels were found in this group of patients as compared
to those without deposits.
In contrast to IgA deposits, 1gM deposits as well as accom-
panying deposits of C3, when present, were lumpy in all but one
patient and resembled 1gM deposits in the sclerotic and hyalin-
ized gbomeruli. As such, they do not likely result from immune
complex deposition but rather from insudation of plasma pro-
teins into the blood vessel walls. The association between the
presence of 1gM deposits and vascular and glomerular hyalino-
sis and sclerosis has already been reported [2, 26—29]. In the
vast majority of cases, the deposition of 1gM and the develop-
ment of vascular lesions is probably causally related to systemic
hypertension. Four of our 28 patients with 1gM deposits were,
however, normotensive. In one, IgM deposits were granular
and we cannot exclude immune complex pathogenesis. In the
other three patients 1gM deposits were lumpy. We conclude
with caution on the basis of the remaining three cases that
insudation of plasma proteins into the blood vessel walls may
precede the appearance of systemic hypertension. This finding,
supported by several reports that vascular lesions are common
in normotensive patients with IgA GN [1, 4, 5, 7, 11] agrees
with the idea that other factors than systemic hypertension may
be involved in the development of vascular lesions [5, 6, 11].
Granular deposits of C3 in the extraglomerular blood vessels
have been previously reported as a common immunofluorescent
finding in various kidney diseases [7, 16, 27, 30—331 as well as in
normal kidney [32, 34]. In our patients vascular C3 deposits
were found in 317 cases (74%). In a minority of patients they
were accompanied by C4 and/or Clq.
It is controversial whether or not C3 deposits are important
for the pathogenesis of vascular lesions. Some authors believe
that C3 deposits are clearly associated with vascular lesions [2,
7, 27, 31], while others ignore them as nonspecific [34, 35]. The
results of our study suggest that vascular C3 deposits are of
little importance for the development of vascular lesions, since
we were not able to prove any correlation between the presence
of C3 deposits and vascular lesions. Moreover, we believe that
they are not disease-related at all, as they appear in a similar
incidence not only in various kidney diseases but in healthy
persons as well; we have found vascular C3 deposits in 70% of
individuals without renal disease [34]. The mechanism of C3
deposition is not clear and demands further investigation.
In conclusion, the results of our study suggest that deposits of
immune complexes as well as isolated deposits of complement
components in the extraglomerular blood vessels in patients
with IgA GN do not play a significant role in the development of
vascular lesions and progression of the disease. Lumpy 1gM
deposits, on the contrary, were clearly associated with the
advanced vascular lesions and glomerubosclerosis and are prob-
ably a part of the non-immune mediated progression of IgA GN.
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